Articles in Stocks

Zacks.com

AZN Reports Data on Fostamatinib - Analyst Blog

AstraZeneca ( AZN ) announced top-line data from the phase III study (OSKIRA-1: n = 923) on its rheumatoid arthritis (RA) candidate fostamatinib. The study assessed the safety and efficacy... Read >>

Zacks.com

KBR Receives Contract from Subsea 7 - Analyst Blog

Recently , KBR Inc . ( KBR ) announced that it has received a contract from Subsea 7 SA ( SUBCY ) to provide topsides design for the Chevron Lianzi development project. The financial... Read >>

Zacks.com

McDermott Downgraded to Sell - Analyst Blog

Zacks Investment Research downgraded McDermott International ( MDR ), an energy-focused engineering and construction firm, to a Zacks Rank #4 (Sell) on Apr 6, 2013.   Why the... Read >>

Zacks.com

UPS Challenges EU Verdict on TNT - Analyst Blog

United Parcel Service, Inc. ( UPS ) and TNT Express have once hit the headlines for their attempt to win back the lost ground on proposed acquisition plans. Going by market reports, UPS has... Read >>

Zacks.com

Fifth KB Home Project in Stapleton - Analyst Blog

One of the leading home building companies in the United States, KB Home ( KBH ) unveiled a new community of homes called Stapleton Conservatory Green. Homebuyers caught a glimpse of the... Read >>

Zacks.com

Simon Property Soars to New 52-Week High - Analyst Blog

Shares of Simon Property Group Inc. ( SPG ) touched a 52-week high of $166.30 on Friday, Apr 5, 2013, as it gained momentum from better-than-expected fourth-quarter 2012 results. The... Read >>

Zacks.com

SunPower, SRP Dedicate PV Facility - Analyst Blog

SunPower Corporation ( SPWR ) along with its partner Salt River Project (:SRP) dedicated the solar photovoltaic (PV) power plant at Arizona State University (ASU) in Mesa, AZ. This 1... Read >>

Zacks.com

CU Bancorp Upped to Strong Buy - Analyst Blog

On Apr 3, Zacks Investment Research upgraded CU Bancorp ( CUNB ) to a Zacks Rank #1 (Strong Buy). Why the Upgrade? CU Bancorp has been witnessing rising earnings estimates based... Read >>

Zacks.com

Illumina Introduces TruSight Tumor - Analyst Blog

Recently, Illumina Inc. ( ILMN ) expanded its suite of TruSight content sets by adding TruSight Tumor to its portfolio. TruSight's content set is created according to different diseases.... Read >>

Zacks.com

Data Presented on Bayer's ATX-101 - Analyst Blog

Bayer AG ( BAYRY ) recently presented positive results on ATX-101 at the 11th Anti-Aging Medicine World Congress (AMWC) 2013. ATX-101 is being developed for the reduction of unwanted fat... Read >>